The present invention relates to low dose pharmaceutical compositions comprising the aromatase inhibitor 4 4 [fluoro (1 H 1 2 4 triazol 1 yl)methylene]bisbenzonitrile as the active ingredient in a suitable carrier. The present invention also relates to a process for their preparation and to their use as medicaments.